Daiichi Sankyo promoted Hiroyuki Okuzawa to CEO, and he will take over from Sunao Manabe on April 1.
“Speech is how we naturally communicate. This funding moves us closer to a world where digital interactions happen by voice—fluid, natural and as effortless as a conversation,” said ...
(RTTNews) - Japanese healthcare firm Daiichi Sankyo Co., Ltd (DSKYF.PK) announced Friday the appointment of Hiroyuki Okuzawa as Chief Executive Officer, succeeding Sunao Manabe, with effect from ...
TOKYO, January 31, 2025--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO ...
eight important key data readouts just in a period of one year and so there'll be a very exciting time for data for Daiichi Sankyo in fiscal year 2025. Okay, that's it for my side and let me turn ...
TOKYO, January 31, 2025--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effective ...
So, let's take a look at this theory and try to break down the relationship Uranus could have with the Voice of All Things. The Ancient Weapons from One Piece are incredibly mysterious ...
Daiichi Sankyo’s board of directors followed the nomination committee’s report in making the appointment. Credit: ArDanMe/Shutterstock. Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed ...
NEW YORK – AstraZeneca and Daiichi Sankyo have begun treating high-risk non-small cell lung cancer patients with their TROP2-directed antibody drug conjugate Datroway (datopotamab deruxtecan) and ...
Dive into the heart of Africa’s green transition with our latest issue, where we uncover the bold solutions shaping the continent’s sustainable future. From groundbreaking insights at COP29 to South ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback